Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
31.98
+2.64 (9.00%)
Apr 29, 2026, 4:08 PM HKT
HKG:3378 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Cash & Equivalents | 614.4 | 161.21 | 162 |
| Short-Term Investments | - | 12.67 | 42.36 |
| Trading Asset Securities | 37.76 | - | - |
| Cash & Short-Term Investments | 652.17 | 173.88 | 204.36 |
| Cash Growth | 275.07% | -14.92% | - |
| Prepaid Expenses | 39.66 | 68.91 | 93.9 |
| Other Current Assets | - | - | 0.5 |
| Total Current Assets | 691.83 | 242.79 | 298.76 |
| Property, Plant & Equipment | 19.95 | 24.13 | 24 |
| Long-Term Investments | 222.96 | 233.78 | 262.39 |
| Other Intangible Assets | 0.42 | 0.45 | 0.56 |
| Other Long-Term Assets | 0.33 | 0.33 | 0.53 |
| Total Assets | 935.48 | 501.47 | 586.24 |
| Accounts Payable | 18.87 | 12.29 | 12.94 |
| Accrued Expenses | 7.6 | 2.8 | 2.56 |
| Short-Term Debt | 10 | - | - |
| Current Portion of Long-Term Debt | 20 | - | - |
| Current Portion of Leases | 3.52 | 3.17 | 3.2 |
| Current Income Taxes Payable | 7.02 | 7.98 | 7.07 |
| Other Current Liabilities | 28.11 | 171.2 | 37.11 |
| Total Current Liabilities | 95.11 | 197.44 | 62.87 |
| Long-Term Debt | 17 | - | - |
| Long-Term Leases | 5.35 | 8.66 | 11.83 |
| Long-Term Deferred Tax Liabilities | 70.4 | 78.77 | 90.47 |
| Other Long-Term Liabilities | - | - | 101.49 |
| Total Liabilities | 187.86 | 284.87 | 266.66 |
| Common Stock | 13.62 | 11.79 | 9.53 |
| Retained Earnings | - | -72.38 | 0.53 |
| Comprehensive Income & Other | 684.12 | 226.83 | 258.07 |
| Total Common Equity | 697.74 | 166.24 | 268.13 |
| Minority Interest | 49.88 | 50.37 | 51.45 |
| Shareholders' Equity | 747.62 | 216.6 | 319.58 |
| Total Liabilities & Equity | 935.48 | 501.47 | 586.24 |
| Total Debt | 55.86 | 11.83 | 15.03 |
| Net Cash (Debt) | 596.3 | 162.05 | 189.33 |
| Net Cash Growth | 267.98% | -14.41% | - |
| Net Cash Per Share | 5.04 | 14.82 | 25.95 |
| Filing Date Shares Outstanding | 13.62 | 11.79 | 7.3 |
| Total Common Shares Outstanding | 13.62 | 11.79 | 7.3 |
| Working Capital | 596.71 | 45.35 | 235.89 |
| Book Value Per Share | 51.22 | 14.10 | 36.75 |
| Tangible Book Value | 697.32 | 165.79 | 267.57 |
| Tangible Book Value Per Share | 51.19 | 14.06 | 36.68 |
| Machinery | - | 5.14 | 4.1 |
| Construction In Progress | - | 2.66 | 6.41 |
| Leasehold Improvements | - | 8.2 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.